Vanguard Group’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.9M | Buy |
|
|||||
|
2025
Q1 | $10.8M | Buy |
|
|||||
|
2024
Q4 | $15.7M | Buy |
|
|||||
|
2024
Q3 | $30.2M | Sell |
|
|||||
|
2024
Q2 | $29.7M | Buy |
|
|||||
|
2024
Q1 | $27.3M | Sell |
|
|||||
|
2023
Q4 | $38M | Buy |
|
|||||
|
2023
Q3 | $21.1M | Buy |
|
|||||
|
2023
Q2 | $15.1M | Buy |
|
|||||
|
2023
Q1 | $5.23M | Buy |
|
|||||
|
2022
Q4 | $3.61M | Buy |
|
|||||
|
2022
Q3 | $4.07M | Buy |
|
|||||
|
2022
Q2 | $5.75M | Buy |
|
|||||
|
2022
Q1 | $5.91M | Sell |
|
|||||
|
2021
Q4 | $20.1M | Sell |
|
|||||
|
2021
Q3 | $75.6M | Buy |
|
|||||
|
2021
Q2 | $68.9M | Buy |
|
|||||
|
2021
Q1 | $30.7M | Buy |
|
|||||
|
2020
Q4 | $38.6M | Buy |
|